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Image-Derived Input Function from the Vena Cava for
18F-FDG PET Studies in Rats and Mice
Bernard Lanz1, Carole Poitry-Yamate2, and Rolf Gruetter1–4
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2Center for Biomedical Imaging, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland; 3Department of Radiology,
University of Lausanne, Lausanne, Switzerland; and 4Department of Radiology, University of Geneva, Geneva, Switzerland
Measurement of arterial input function is a restrictive aspect for
quantitative 18F-FDG PET studies in rodents because of their small
total blood volume and the related difficulties in withdrawing blood.
Methods: In the present study, we took advantage of the high spa-
tial resolution of a recent dedicated small-animal scanner to extract
the input function from the 18F-FDG PET images in Sprague–Dawley
rats (n5 4) and C57BL/6 mice (n5 5), using the vena cava. In the rat
experiments, the validation of the image-derived input function
(IDIF) method was made using an external microvolumetric blood
counter as reference for the determination of the arterial input func-
tion, the measurement of which was confirmed by additional man-
ually obtained blood samples. Correction for tracer bolus dispersion
in blood between the vena cava and the arterial tree was applied. In
addition, simulation studies were undertaken to probe the impact of
the different IDIF extraction approaches on the determined cerebral
metabolic rate of glucose (CMRGlc). In the mice measurements, the
IDIF was used to compute the CMRGlc, which was compared with
previously reported values, using the Patlak approach. Results: The
presented IDIF from the vena cava showed a robust determination
of CMRGlc using either the compartmental modeling or the Patlak
approach, even without bolus dispersion correction or blood sam-
pling, with an underestimation of CMRGlc of 7% ± 16% as compared
with the reference data. Using this approach in the mice experiments,
we measured a cerebral metabolic rate in the cortex of 0.22 ± 0.10
μmol/g/min (mean ± SD), in good agreement with previous 18F-FDG
studies in the mouse brain. In the rat experiments, dispersion cor-
rection of the IDIF and additional scaling of the IDIF using a single
manual blood sample enabled an optimized determination of CMRGlc,
with an underestimation of 6% ± 7%. Conclusion: The vena cava
time–activity curve is therefore a minimally invasive alternative for the
measurement of the 18F-FDG input function in rats and mice, with-
out the complications associated with repetitive blood sampling.
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arterial input function; rodents; vena cava
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Glucose metabolism can be efficiently measured in vivo using
PET and adequate radiotracers, such as the glucose analog 18F-
FDG, opening the way to a large range of metabolic studies in
rodents (1). The quantification of the metabolic rate of glucose
(MRGlc) from 18F-FDG PET experiments requires the knowledge
of the arterial input function (AIF), which is typically measured by
serial arterial blood sampling (2). However, in small animals, the
total amount of blood is limited and continuous blood sampling
over the entire experiment duration (on the order of 45 min) is
technically challenging and might affect the physiology of the
animal.
Several methods have been developed in the last decade to
overcome this difficulty. New microfluidic blood sampling devices
were developed to minimize the amount of blood withdrawn (3).
Another method minimizing blood losses is the use of an arterio-
venous shunt, coupled with either a g coincidence counter (4) or
a b probe (5). A further approach is to insert a b probe directly in
the femoral artery, to measure the blood activity without blood
withdrawal (6). Although the AIF can be measured with high
temporal resolution using this method, the insertion of the probe
and the correction for background radioactivity remains techni-
cally challenging.
Several studies reported the extraction of the input function
from the PET images. In human studies, the carotid arteries (7),
the heart (8), or the ascending aorta (9) were successfully used to
measure the 18F-FDG input function, opening the way to facili-
tated clinical MRGlc measurements. In rodents, the extraction of
18F-FDG image-derived input functions (IDIF) was generally fo-
cused on the heart (10), because of the limited spatial resolution of
small-animal PET scanners and the related difficulty to delineate
blood vessels. However, IDIF extraction from the heart in small
animals is limited by the large partial-volume effect and spillover
from the myocardium, requiring the application of elaborate sta-
tistical methods such as factor analysis (11–13) to overcome this
limitation by deconvolving the blood and myocardium contribu-
tions to the heart time–activity curve. Finally, simplified glucose
uptake measurements using standard input functions scaled by at
least 1 blood sample were developed (14). The limitation of this
method lies in the necessity of a rigid and repeatable infusion
protocol. Moreover, the physiologic conditions of the animal
(e.g., age, disease model, anesthesia) might affect the evolution
of the tracer in the precursor pool.
The aim of the present study was to take advantage of the high
spatial resolution and sensitivity of recent small-animal PET
scanners to extract the 18F-FDG input function from the PET
image of small rodents, using a large blood vessel, here the
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inferior vena cava (;2 mm diameter). Compared with the heart
ventricles, the vena cava is much less affected by spill-in contam-
ination from neighboring tissues and an image-derived input func-
tion might be extracted with minimal postprocessing. The vena
cava is also expected to be directly visible on the PET images in
the first time frames after the bolus 18F-FDG injection through the
femoral or tail vein. The accuracy and precision of the IDIF were
evaluated by comparison with an external automated blood
counter AIF and with manual blood sampling.
MATERIALS AND METHODS
Animal Preparation
All animal preparation procedures were performed in accordance
with local and federal guidelines and were approved by the local
ethics committee from the canton Vaud. Four healthy Sprague–Daw-
ley rats (2816 18 g, mean6 SD), housed with free access to food and
water, were anesthetized with 2% isoflurane in O2 during surgery. One
femoral artery was cannulated for manual blood sampling. The second
femoral artery was cannulated for the measurement of the arterial
input function in the external microvolumetric b blood counter (15).
Both femoral veins were catheterized. One vein was used for the in-
jection of 18F-FDG, and the second one completed the arteriovenous
shunt guided through the blood counter (Fig. 1). In a second step, 5
C57BL/6 mice (30 6 3 g, mean 6 SD), housed with free access to
food and water, were anesthetized with 2% isoflurane in O2 during the
cannulation of the tail vein for tracer injection.
After preparation, the animal was placed on the heated carbon fiber
bed of the PET scanner, and anesthesia was maintained with 1.3%–
1.8% isoflurane in 100% O2. Breathing rate and body temperature
were continuously monitored through a respiration pillow and a rectal
thermosensor, respectively (SA Instruments Inc.). Body temperature
was maintained at a constant (37.5C 6 0.5C) by adjusting the cur-
rent in the heating bed.
18F-FDG PET Scan
All the PET data were acquired on an avalanche photodiode–based
LabPET-4 small-animal scanner (Gamma Medica-Ideas Inc., formerly
Advanced Molecular Imaging Inc.) (16–18). The reconstructed stan-
dard voxel size is 0.5 · 0.5 · 1.18 mm, and the achieved intrinsic
radial and axial resolutions are 1.15 and 1.09 mm (16,18–20). Data
were collected in list mode (16), which allows full flexibility in the
choice of time frames in the reconstruction protocol.
The rats were positioned prone, head first, and the field of view was
centered on the thoracic region, caudal to the heart. Within the
first minute of the 45-min PET acquisition, a bolus of 18F-FDG was
manually injected through the right femoral vein (injected dose, 59 6
8 MBq) and followed by a saline chase.
The mice were scanned prone, head first, with the field of view
covering the region from the brain to the vena cava (;1 cm caudal to
the heart). A bolus of 18F-FDG was manually injected through the tail
vein during the first minute of the 30-min PET acquisition (injected
dose, 57 6 1 MBq) and followed by a saline chase.
The images were reconstructed using the maximum likelihood
expectation maximization iterative reconstruction algorithm (21)
with a circular field of view of 80 mm in diameter for rats and
46 mm for mice. The data were reconstructed dynamically with
a varying temporal resolution (5 s over the first 2 min, 30 s over
3 min, 2 min over 10 min, and 5 min over the remaining acquisition
time). The high temporal resolution at the time of 18F-FDG injection
is necessary to characterize properly the input function, which varies
rapidly during this period. The LabPET-4 built-in calibration method
was used to obtain quantified PET images in Bq/mL. Scatter cor-
rection was applied using a detection energy window (250–650 keV)
and a coincidence timing window of 22.2 ns. No attenuation cor-
rections were applied. The postprocessing of the PET images and
activity density extraction from the volumes of interest (VOIs) were
undertaken with the PMOD 2.95 software (PMOD Technologies
Ltd.).
Using the first time frames after the 18F-FDG injection, we located
the inferior vena cava in the PET images by inspecting the maximum-
intensity-projection image in the coronal plane, in which the flow of
the 18F-FDG bolus and the following chase were pinpointed (Fig. 2).
The time frame corresponding to the bolus first-pass was then selected
for the construction of the VOI, drawn over the corresponding axial
slices. The VOI consisted of 1-mm square regions of interest drawn
over 4 successive axial slices (each of 1.18-mm thickness), placed
on the inferior vena cava, at a sufficient distance (.6 mm) from the
heart and the kidneys to avoid radioactivity contamination. This pro-
cess resulted in a total VOI of 4.7 mm3. In mice, a second VOI (1 ·
1 · 2.36 mm3) was placed in the cortex to measure brain tissue–
activity curve to determine the cerebral metabolic rate of glucose
(CMRGlc).
Flow-Through Blood Counter
A microvolumetric b blood counter (15) was used for the contin-
uous measurement of the arterial input function in rats. This flow-
through blood counter was part of an arteriovenous shunt between
the left femoral artery and the left femoral vein. The arteriovenous
loop was built in a way similar to what was presented previously (4),
with some minor modifications. No 3-way valve was inserted on the
arterial side before the blood counter, to avoid additional dead-volume
between the sampling point and the detector and the related delay in
the arterial input function measurement. The loop consisted of poly-
ethylene tubing PE-50 (inner diameter, 0.58 mm; outer diameter,
0.965 mm; 2.6 mL/cm). The length between the sampling point and
the detector was 356 2 cm. No blood sampling was made through the
shunt, to avoid any possible interruption of blood flow in the loop and
related artifacts on the measured input function. The measurement on
FIGURE 1. Illustration of the experimental setup used for rats in this
study. 1) PET field of view. 2) Manual blood sampling. 3) 18F-FDG in-
jection. PET field of view was centered on region caudal to heart, to
image vena cava. External microvolumetric blood counter was measur-
ing blood activity in arteriovenous loop between left femoral artery (A)
and vein (V). 18F-FDG injection was done in right femoral vein, and right
femoral artery was used for manual blood sampling. During acquisition,
no injection or blood withdrawal was made on left arteriovenous loop, to
avoid perturbing measurement with external blood counter.
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the microvolumetric b blood counter was started simultaneously with
the beginning of the PET acquisition, and the data were acquired with
a temporal resolution of 1 s. The arterial input function measured with
the blood counter was corrected for the radioactive decay (relative to
the start of the acquisition). The blood flow through the arteriovenous
loop, verified at the beginning and the end of the experiment using
the 3-way valve, was on the order of 20 mL/s, corresponding to a
blood transit time from the femoral artery to the blood counter of less
than 5 s.
Manual Blood Sampling
The accuracy of the input function measurements obtained with the
microvolumetric blood counter or derived from the PET image in rats
was verified by sampling blood at discrete time points. Manual blood
samples (206 0.5 mL, mean6 SD) were taken from the right femoral
artery at 1.5, 5, 10, 20, and 35 min after the injection and stored into
preweighed and postweighed Eppendorf tubes. The tubes were later
scanned in a g counter (Wallac 1470 WIZARD Gamma Counter;
Wallac OY). The measured radioactivity was corrected for the radio-
active decay (relative to the start of the acquisition), and blood radio-
activity density was calculated using the difference in weight of the
filled Eppendorf tubes.
CMRGlc Measurement in Mice
The CMRGlc was determined in mice with the Patlak plot method
(22,23), using the raw IDIF from the vena cava and the tissue activity
from the cortex. The plasma activity was estimated from the whole-
blood activity using a monoexponential cor-
rection function, as previously published (3).
The plasma glucose concentration was
measured with a manual blood sample from
the tail artery at the end of the PET acquisi-
tion and the lumped constant (LC). LC for
18F-FDG metabolism was fixed to 0.6, as pre-
viously found in mice (24). To avoid an effect
of a nonzero FDG-6P dephosphorylation rate
(k∗4) (25), we limited the acquisition to 30 min.
Correction for Tracer Dispersion
Between Sampling Locations
In a further step, an additional processing
was applied to the IDIF obtained in the rat to
correct for tracer dispersion in the blood-
stream. The IDIF was measured in the in-
ferior vena cava, whereas the manual blood
samples and the arterial input function de-
termined with the microvolumetric b blood
counter were measured in the right and left
femoral arteries. The injection of 18F-FDG
was made through the femoral vein. Between
the IDIF sampling site and the femoral
arteries, the tracer travels twice through the
heart and passes through the pulmonary cir-
culation, a highly branched circulatory route,
resulting in a dispersion of the tracer and time
delays. The dispersion of the tracer bolus be-
tween the vena cava and the femoral arteries
was thus considered as follows.
A double-exponential dispersion function
was used to model the tracer dispersion
between the inferior vena cava and the
femoral artery, similar to what has been
previously introduced in CT studies using
iodinated contrast agents (26) and is an ex-
tension of the monoexponential dispersion
function applied in 15O PET blood flow studies (27–29).
The explicit form of the applied dispersion function was:
dðtÞ 5 a

b  ð1=t1Þexp

2
t
t1

1 ð1 2 bÞð1=t2Þexp

2
t
t2

; Eq. 1
where b represents the weight of each exponential function in the
dispersion function. Note that
RN
0 dðtÞdt 5 a. The factor a was in-
troduced to take into account a possible systematic difference in total
specific activity measured in the vena cava and in the femoral artery
due to, for example, tracer uptake between the 2 sampling sites or
calibration effects between the different measurement methods as well
as spillover effects.
The dispersion-corrected input function g(t) was calculated as the
convolution of the input function measured in the inferior vena cava
with the dispersion function:
gðtÞ 5 C∗VenaCavaðtÞ5dðtÞ 5
ðt
0
C∗VenaCavaðt  2   t9Þdðt9Þdt9: Eq. 2
The parameters a, b, t1, and t2 were optimized by fitting the dis-
persion-corrected IDIF measured in the inferior vena cava to the
arterial input function measured with the microvolumetric b blood
counter for each of the 4 experiments using the function presented
in Equation 1.
FIGURE 2. PET images of vena cava in rat during first passage of 18F-FDG bolus, used to define
VOI for image-derived input function. (A) Maximum-intensity-projection (MIP) maps on coronal plane,
used as temporal marker to determine time frame at which tracer bolus is flowing through vena cava.
18F-FDG was injected in femoral vein, and tracer bolus flowing from rear part of animal to heart can
be observed in reconstruction time frame of 5 s. Last MIP image shows steady-state 18F-FDG
labeling 42 min after tracer injection, underlining low 18F-FDG tissue uptake around vena cava. Time
indicated under each image corresponds to middle of reconstructed time frame, where t 5 0 s was
set at start of 18F-FDG injection. (B) Axial slice of vena cava during time frame corresponding to first
passage of 18F-FDG bolus, as observed in MIP. VOI was defined as 1 · 1 mm square regions on 4
consecutive slices (slice thickness, 1.18 mm), centered on highest activity part of vein. (C) Sagittal
slice showing total VOI, consisting of 4 cuboids, resulting in 4.7 mm3 volume of detection. This view
represents snapshot of bolus of tracer flowing from rear part of animal to heart (on left of picture).
A 5 anterior; F 5 feet; H 5 head; L 5 left; P 5 posterior; R 5 right.
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The convolution operations and parameter optimizations were un-
dertaken with Matlab (The MathWorks), using a modified Levenberg–
Marquardt nonlinear regression method. Generic values of the param-
eters a, b, t1, and t2 were estimated as their respective mean value
found over the 4 rats. A corresponding generic dispersion function
was generated and used to create dispersion-corrected IDIFs for every
animal. Three different methods of dispersion-corrected IDIFs from
the vena cava were analyzed (summarized in Table 2): first, the activity
measured in the vena cava VOI for each animal was corrected using the
generic parameters for the dispersion function (Table 1). In the second
method, the scaling parameter a was set to 1, whereas the same values
were used for the other parameters b, t1, and t2 (Table 1). Finally, in the
third method, the generic parameter values were used (Table 1), whereas
the first manual blood sample at 1.5 min was used to scale the disper-
sion-corrected input function such as (Eq. 2) g(1.5 min) 5 sample(t 5
1.5 min). In addition, the approaches using IDIF uncorrected for tracer
dispersion were analyzed using the raw IDIF from the vena cava
(method 4) and the raw IDIF from the vena cava scaled with the first
manual blood sample at 1.5 min (method 5), as in method 3.
The validity of these generic values were tested by comparing each
dispersion-corrected IDIF, using the generic values, with the re-
spective arterial input function measured with the microvolumetric b
blood counter and the manual blood samples. The effect of the various
extracted IDIF on the determined CMRGlc using either the compart-
mental modeling approach of 18F-FDG uptake or the Patlak approach
was evaluated on the basis of simulated brain tissue 18F-FDG uptake
curves, generated with the compartmental model of 18F-FDG uptake,
the AIF measured with the microvolumetric b blood counter in each
rat, and typical metabolic constants (K1 5 0.221 min21, k2 5
0.164 min21, and k3 5 0.037 min21; plasma glucose level 5 5 mM
and LC 5 0.71 (30)). For each animal, the cerebral metabolic rate of
glucose was then estimated with the compartmental modeling ap-
proach (CMRGlc) or the Patlak approach (CMRGlc_Patlak) using each
of the IDIF extraction approaches and the simulated tissue–activity
curve. The ratio of the determined CMRGlc or CMRGlc_Patlak to the
true CMRGlc was then averaged for all rats and reported. Metabolic
modeling and parameter estimation were undertaken with Matlab,
using a modified Levenberg–Marquardt nonlinear regression method.
RESULTS
Image-Derived Input Function from Tracer Activity in
Vena Cava
The radioactivity measured in the vena cava typically presents 2
sharp peaks, corresponding to the bolus passage of 18F-FDG fol-
lowed by the saline chase advancing the remaining tracer from the
infusion line into the circulation (Fig. 3). Compared with the input
function measured with the microvolumetric blood counter, the
radioactivity bolus measured in the vena cava was shorter and
reached a higher maximum. However, 100 s after the start of
the PET acquisition (about 1 min after the tracer injection), the
time course of the radioactivity in the vena cava closely paralleled
that of the blood counter and the manual blood samples. This
reflects an effect of tracer dispersion in the blood, between the
vena cava and the femoral artery, used as sampling point for the
external blood counter.
To validate the measurements of blood radioactivity using the
microvolumetric blood counter placed in the arteriovenous shunt,
manual arterial blood samples were measured (Fig. 3). In all the
rats, the input function measured with the blood counter in the
arteriovenous shunt matched the blood activity measured by man-
ual sampling, confirming the accuracy of the blood counter mea-
surement. The tracer bolus was detected within 3 s after the in-
jection, when measured with the blood counter.
Correction for Tracer Dispersion Between
Sampling Locations
To determine the transfer function characterizing the dispersion
between the 2 input functions for each animal, the raw IDIF
convolved with the biexponential dispersion function (Eq. 1) was
fitted to the activity curve measured with the blood counter by
adjusting a, b, t1, and t2 in Equation 1, summarized in Table 1.
The factor a was found to be slightly higher than 1, reflecting
a general underestimation of the IDIF possibly due to spill-out
of blood activity from the VOI.
The averaged scaling factor found in method 3, using a single
blood sample at 1.5 min, was 1.09 6 0.12 (n 5 4). The averaged
scaling factor found in method 5 with the same blood sample was
1.246 0.11 (n5 4). For each animal, the ratio of the area under the
curve (AUC) of the IDIF measured in the vena cava and the AUC
measured with the blood counter was calculated, showing an AUC
measured with the IDIF close to that measured with the external
loop (third row, Table 2). The effect on the estimated CMRGlc using
the compartmental modeling approach or the Patlak approach was
analyzed by calculating the ratio of the CMRGlc obtained with each
IDIF approach to the true CMRGlc used to generate the simulated
tissue activity curves (fourth and fifth rows, Table 2).
TABLE 1
Parameters Characterizing Dispersion Function of Tracer in
Blood, from Vena Cava to Blood Counter Sampling Point in
Femoral Artery
Parameter a (-) b (-) τ1 (s) τ2 (s)
Mean 1.10 0.62 20 180
SD 0.17 0.13 8 86
n 5 4. Values represent mean and SD over 4 rats. For each
animal, parameters were determined by fitting dispersion-
corrected image-derived vena cava input function to arterial input
function measured with external microvolumetric blood counter.
(-) 5 values are dimensionless.
FIGURE 3. Arterial input function measured in femoral artery with
microvolumetric blood counter (gray line), manual arterial blood samples
(white circles), and time–activity curve measured in vena cava, cor-
rected for time delay (red line). Inset shows first 300 s of those 2 curves.
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When correcting the image-derived input function using the
generic dispersion function and using the assumptions of method 1
(a, b, t1, and t2 fixed to their mean values listed in Table 1),
excellent agreement with both the arterial input function measured
with the external blood counter and the manual samples was
noted. When correcting the IDIF for dispersion using method 3
(b, t1, and t2 fixed to their mean values listed in Table 1 and
a single blood sample measured 1.5 min after injection used to
scale the input function), possible discrepancy in the AUC be-
tween the IDIF and the reference AIF due to partial-volume effects
was minimized, which increased the robustness of the IDIF de-
termined on single animals (Fig. 4B; Table 2, method 3).
Sensitivity of CMRGlc and CMRGlc_Patlak to Different IDIF
Approaches in Rats
The CMRGlc values estimated with the different IDIF approaches
showed a consistent recovery of the true CMRGlc value used to generate
the simulated tissue activity curves, both for the metabolic modeling
approach (CMRGlc) and for the Patlak approach (CMRGlc_Patlak),
within 10% of accuracy except for method 5, for which the raw
IDIF was scaled with the first blood sample taken 1.5 min after
tracer injection (Table 2). Interestingly, the raw IDIF gave results
similar to the methods considering dispersion-corrected IDIF. In
method 3, scaling the dispersion-corrected IDIF with a single blood
sample measured 1.5 min after 18F-FDG injection enabled an increased
robustness of the determined CMRGlc and CMRGlc_Patlak across animals.
IDIF and CMRGlc Measurement in Mice
CMRGlc was determined in the mouse cerebral cortex (n5 5) by
applying the Patlak plot analysis using the raw IDIF from the vena
cava. A typical input function and Patlak analysis are shown in
Figure 5. The average CMRGlc value was 0.22 6 0.10 mmol/g/min,
for an average glycemia of 4.9 6 3.6 mM.
DISCUSSION
In this study, we present a method to measure an image-derived
18F-FDG input function in rodents from the inferior vena cava,
readily identified in the 18F-FDG PET image by the first passage of
the 18F-FDG bolus. Although affected by tracer dispersion effects
in blood during the first minute after the bolus injection, this input
function follows closely the standard AIF measured by external blood
sampling, which makes it a technically simple alternative for CMRGlc
measurements in rodents using 18F-FDG. In order to take into account
effects of tracer dispersion between the vena cava and the arteries, in
which the arterial input function is commonlymeasured, a biexponential
dispersion function was introduced, for which parameters were de-
termined by adjusting the dispersion-corrected IDIF to the arterial
input function measured with an external blood counter, used as
reference. To optimize the accuracy of the IDIF, the dispersion-
corrected input function was scaled using a single blood sample,
resulting in an increased accuracy of the IDIF extraction in single
animals.
Blood vessels are difficult to identify in PET images of rodents
and when located, the relatively low spatial resolution of small-
animal PET scanners can lead to partial-volume effects and
positron diffusion leads to spillover contaminations, typical for
VOIs measured in the myocardium (10).
The inferior vena cava has the advantage of being sufficiently
distal (compared with the positron range) from large organs with
significant 18F-FDG uptake, such as the heart and the kidneys,
while still having a reasonably large diameter (1–2 mm in mice
and 2–3 mm in rats (31–33)) suitable to be resolved by the Lab-
PET-4 (radial resolution, 1.1 mm) and the positron range in tissue
(1 mm for 18F (34)), thereby minimizing potential partial-volume
effects and spillover contaminations or losses. In all the measured
animals, the maximum-intensity projection map could be conve-
niently used to locate the time frame corresponding to the first
passage of 18F-FDG through the vena cava (Fig. 2). Taking ad-
vantage of the high spatial resolution of the small-animal LabPET-
4 scanner, the VOI was placed over the inferior vena cava at this
particular time frame. The vena cava presented the characteristics
of being identifiable on the first time frames of the PET recon-
struction after the 18F-FDG bolus injection through the tail vein or
femoral vein, without requiring additional anatomic images. In
TABLE 2
Overview of 5 Methods Used to Determine 18F-FDG Input Function from Vena Cava Time–Activity Curve in Rat
IDIF
extraction approach
Method 1,
dispersion-corrected
IDIF
Method 2,
dispersion-corrected
IDIF, a 5 1
Method 3,
dispersion-corrected
IDIF, 1 blood sample
Method 4,
raw IDIF
Method 5, raw
IDIF, 1 blood
sample
Value of parameter a 1.10 1 1 — —
Scaling with 1 manual
blood sample
No No Yes No Yes
AUC ratio (-) 1.02 ± 0.16 0.93 ± 0.15 1.00 ± 0.06 0.93 ± 0.15 1.15 ± 0.12
CMRGlc ratio (-) 0.94 ± 0.16 1.03 ± 0.18 0.94 ± 0.07 0.93 ± 0.16 0.75 ± 0.09
CMRGlc, Patlak ratio (-) 0.91 ± 0.16 1.00 ± 0.16 0.92 ± 0.07 1.00 ± 0.16 0.81 ± 0.09
For methods 1–3, parameters of generic dispersion function used in dispersion correction (Eq. 1) were set to their average values found
on the 4 rats (Table 1). In methods 2 and 3, parameter a was set to 1 in generic dispersion function. In method 3, manual blood sample
withdrawn 1.5 min after infusion was used as scaling reference for corrected input function. In method 4, raw IDIF from vena cava was
used. In method 5, manual blood sample withdrawn 1.5 min after infusion was used as scaling reference for raw IDIF. Third line
summarizes ratio of AUC found with different image-derived input function and AUC of arterial input function measured with external
blood counter. Uncertainty in AUC represents SEM. Fourth and fifth lines show results of simulation studies undertaken to test effects of
different IDIF approaches on determination of CMRGlc. In fourth line, ratio of CMRGlc determined by compartmental modeling on simulated
brain tissue–activity to true CMRGlc used to simulate tissue–activity curve is summarized, whereas last line shows results for CMRGlc_Patlak
determined with Patlak approach. Uncertainty in CMRGlc and CMRGlc_Patlak represents SEM.
(-) 5 values are dimensionless.
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human studies, other large vessels such as the ascending aorta (9)
were used for IDIF determination. In rodents, however, although
the ascending aorta diameter is similar to the vena cava, the as-
cending aorta could not be identified on the first time frames of the
PET reconstruction after the 18F-FDG bolus, probably because of
tracer dispersion in the pulmonary circulation.
The arterial input function measured with the microvolumetric
blood counter was used as a reference for the 18F-FDG input
function measurement. With the arteriovenous shunt, a higher
blood flow through the counter could be used (on the order of
20 mL/s), as compared with an open circuit. For such a high flow,
the dispersion of the tracer in the PE-50 catheter from the femoral
artery to the counter is expected to have a low to negligible effect
on the measured arterial input function, as compared with manual
blood sampling, with an estimated dispersion constant of about
3 s, assuming a monoexponential dispersion function (15). The
excellent agreement between the manual blood sampling and the
arterial input function (Fig. 3) measured with the blood counter
supports this argument. The dispersion in the measurement line
was therefore neglected.
The determination of the metabolic rate of glucose from 18F-
FDG tissue uptake can be undertaken using 3 main methods.
First, MRGlc can be estimated using a simplified single-scan
approach (35,36), at a sufficiently long time after the bolus 18F-
FDG injection so that the contribution of free 18F-FDG activity in
tissue becomes negligible (Equation 30 in Sokoloff et al. (35)). In
this case, only the integral of the 18F-FDG input function enters
into the calculation of MRGlc. The errors in MRGlc are expected to
be proportional to the error in the AUC of the input function. As
a consequence, the MRGlc can be determined directly using the
plasma 18F-FDG activity obtained from the raw IDIF without
correction for dispersion, because the AUC ratio between the
raw IDIF and the AIF reference was 0.93 6 0.15, similar to what
was found in method 2 of the dispersion-correction method.
A second approach to measure the MRGlc is the Patlak method
(22,23). This method is based on the fact that for an irreversibly
trapped tracer, the plot of the following expressions becomes lin-
ear after a given time t* (typically 3–10 min):
C∗t ðtÞ
C∗pðtÞ
  versus 
Ð t
0 C
∗
pðsÞds
C∗pðtÞ
; Eq. 3
where C∗t is the tissue tracer concentration and C
∗
p the plasma
tracer concentration. Both the instantaneous value of the plasma
tracer concentration at time t and its integral from the injection
time (t 5 0) to t (with t. t∗) appear in the calculation of the
MRGlc. For times greater than 1 min after the injection, both the
AUC and the activity value of the raw IDIF from the vena cava
matched the reference arterial input function (Fig. 3). The plasma
18F-FDG activity obtained from the raw IDIF measured in the
vena cava can therefore be directly used to determine the MRGlc
from the Patlak plot without introducing significant bias, as shown
in the last row of Table 2. Applying this method, we estimated an
MRGlc in the mouse cerebral cortex of 0.22 6 0.10 mmol/g/min
(Fig. 5), in good agreement with previous 18F-FDG studies in the
mouse brain (25).
The third MRGlc calculation method requiring the fewest
assumptions is the use of the compartmental model of 18F-FDG
metabolism to fit the kinetics of 18F-FDG tissue uptake (37). In
this case, the MRGlc is derived from the different rate constants
describing 18F-FDG transport and phosphorylation in the tissue.
With this modeling approach, the shape of the input function could
have a significant impact on the derived metabolic fluxes. How-
ever, we showed that when the experimentally determined scaling
parameter a (method 1) or a manual blood sample as scaling
reference (method 3) are used, the dispersion-corrected IDIF from
the vena cava closely matches both the AUC and the shape of the
reference AIF (Fig. 4; Table 2). The scale factor found in method 3
using blood sampling was also close to the experimentally deter-
mined scaling parameter a (method 1) (1.09 6 0.12 vs. 1.10 6
0.17). The presented CMRGlc recovery analysis based on typical
18F-FDG metabolic rates showed a good estimation of CMRGlc
using compartmental modeling with all the dispersion-corrected
IDIF (Table 2). An improvement in the precision and robustness of
the CMRGlc determination was obtained by scaling the dispersion-
corrected IDIF using the first manual blood sample (Table 2,
FIGURE 4. Example of dispersion-corrected image-derived 18F-FDG
input function obtained from vena cava of rat. Correction was made
using dispersion function (Eq. 1) with average parameter values for
a, b, τ1, and τ2 estimated from group of rats (generic dispersion func-
tion). Corrected input function presented here was derived from vena
cava time–activity curve shown in Figure 3. Inset shows first 300 s of
those 2 curves. (A) IDIF was corrected for dispersion using generic
values for parameters a, b, τ1, and τ2 (Eq. 1) determined from the group
of rats (method 1). No blood sample was needed to calibrate curve. (B)
IDIF was corrected for dispersion using generic values for parameters b,
τ1, and τ2 (Eq. 1) determined from group of rats. Input function was
further scaled using first blood sample, measured 1.5 min after tracer
injection (method 3).
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method 3). Interestingly, when the raw IDIF from the vena cava
was used, a similar performance in CMRGlc estimation was
reached, indicating the relative insensitivity of the method to the
exact shape of the bolus during the first 2 min of the 18F-FDG PET
acquisition, as far as the AUC is preserved. However, in the case
of the raw IDIF extraction, scaling the IF using the first blood
sample (method 5) actually degraded the evaluation of CMRGlc,
probably because of the nonnegligible dispersion effects taking
place between venous and arterial blood in the early period after
the bolus injection (1.5 min). This effect is also supported by the
fact that in method 5, the average scale factor found using blood
sampling (1.24 6 0.11) was less close to the average scaling
parameter a found for method 1 (1.10 6 0.17) than when using
method 3 (with dispersion correction), because of the wrong shape
of the input function during the bolus period when dispersion cor-
rection was neglected.
Therefore, the dispersion-corrected IDIF and the raw IDIF can
be used for all the 3 approaches discussed above, without in-
troducing a significant bias in the estimation of the 18F-FDG met-
abolic rate constants. In all 3 methods, the plasma 18F-FDG ac-
tivity can be obtained from the whole-blood activity curve using
a dynamic correction factor (3).
The tracer bolus dispersion in blood between the vena cava and
the femoral vein was modeled using a biexponential dispersion
function, as previously used in 15O PET blood flow measurements
(29). When a monoexponential function (a and b 5 1 in Eq. 3)
was used, the dispersion-corrected IDIF overestimated the blood
activity concentration immediately after the bolus and underesti-
mated the activity at time points later than 400 s in all rats (data
not shown). This observation suggests a more complex dispersion
mechanism than the single mixing cham-
ber model (26), which cannot therefore be
summarized by a monoexponential func-
tion. We noted that the 2 estimated disper-
sion time constants differed by 1 order
of magnitude—that is, 20 and 180 s—
whereas their respective exponential term
had similar weight (b ;0.6). These 2 con-
stants represent 2 different dispersion pro-
cesses between the vena cava and the fem-
oral arteries, likely representing blood
mixing in the pulmonary circulation and
in interstitial tissue. Because the heart is
a major site of 18F-FDG uptake (38), the
bidirectional exchange between blood 18F-
FDG and unmetabolized 18F-FDG in the
myocardial tissue through the coronary cir-
culation could also affect the measured
blood dispersion function.
From the 3 methods treated to generate
a dispersion-corrected input function from
the time–activity curve measured in the
vena cava (Table 2), method 1 and method
3 were the more accurate methods, with an
average difference of less than 2% in the
AUC, compared with the external blood
sampling.
In method 1, the scaling parameter a (Eq.
1) was set to the average value (1.1) found
for the 4 rats. Because a corresponds to the
integral of the dispersion function, a being
10% larger than 1 implies a slight underestimation of the input
function, measured in the vena cava VOI. This underestimation is
most likely related to spill-out of blood activity beyond the VOI
boundary, due to the positron diffusion in tissue before annihilation
and the limited spatial resolution of the scanner. However, CMRGlc
and CMRGlc_Patlak determined in the rat with the raw IDIF (method
4) or with the dispersion-corrected IDIF without scaling (method 2,
a 5 1) showed a good agreement with the reference value. There-
fore, the underestimation of the vena cava activity curve due to
limited spatial resolution or spill-out effects does not seem to be
critical in CMRGlc estimation using 18F-FDG PET in rats.
The approach using the raw IDIF (method 4) was the one
selected to determine CMRGlc_Patlak in mice with minimal inva-
siveness, using the Patlak method. Although good agreement with
previously reported values in mice was obtained (25), the smaller
diameter of the vena cava in mice could affect the determined
IDIF through increased limited spatial resolution or spill-out
effects. Further validations based on dynamic blood sampling in
mice could solve this question. Nonetheless, an increased spill-out
or spatial resolution limits would typically lead to an underesti-
mation of blood activity from the vena cava and thus of the IDIF,
because no major 18F-FDG–metabolizing organ is located close
to the vena cava. For a given tissue activity curve, an underesti-
mation of the blood activity curve due to spill-out would then lead
to an overestimation of CMRGlc_Patlak. However, the values found
for CMRGlc_Patlak in mice in the present study are slightly lower
than previously published values (0.22 6 0.10 vs. 0.34 6 0.09
mmol/g/min (25)), suggesting that the raw IDIF is not subject to
substantial underestimation and supports the validity of the IDIF
method for mice.
FIGURE 5. CMRGlc measurement in mouse cerebral cortex. (A) Localization on horizontal max-
imum-intensity projection of VOI used for extraction of IDIF on vena cava (yellow box, 4.7 μL) and
VOI placed in cortex for measurement of tissue activity curve (red box). (B) Localization of the 1 ·
1 · 2.36 mm VOI in cortex. Image shows 15-min PET acquisition obtained 23 min after bolus
injection of 18F-FDG. (C) IDIF measured from vena cava, corrected for difference in plasma and
whole-blood 18F-FDG concentrations. (D) Patlak plot obtained using tissue–activity curve mea-
sured in cortex and IDIF. A 5 anterior; L 5 left; P 5 posterior; R 5 right.
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In the case of younger mice or smaller species, the vena cava could
reach a critical diameter for which spillover effects have a major
impact on the determined IDIF. On the basis of the diffusion
properties of positron in tissue (34), we calculated that the correction
factor for positron spill-out for a 1-mm square VOI is typically 1.15
for a vena cava diameter of 2.5 mm, close to the parameter a found in
rats (Table 1), indicating that positron diffusion is the dominant
contribution to the scaling parameter a. For a diameter of 2 mm,
the correction factor is 1.31 and increases then critically for diameters
smaller than 1.7 mm (Supplemental Fig. 1; supplemental materials
are available at http://jnm.snmjournals.org). Therefore, in the case of
18F-FDG PET studies on smaller mouse species with smaller vena
cava diameters, further analysis of the impact of spill-out on the IDIF
should be undertaken. Moreover, for particularly young and small
mice, a spill-in contamination from neighboring 18F-FDG–fixing
organs such as the bladder is possible and could hinder the proper
extraction of the IDIF from the vena cava.
In method 3, a blood sample manually withdrawn 1.5 min after the
18F-FDG injection was used to scale the dispersion-corrected input
function. In this case, the difference in the AUC among the animal
group was less than 0.5% on average. Moreover, the SD on the AUC
ratio was also reduced to 6%. As comparison, the SD on the AUC
ratio was 16% in method 1, when no blood sampling was performed.
Moreover, the SD in the determination of CMRGlc and CMRGlc_Patlak
was also substantially reduced to 7% using this approach. We decided
to scale the dispersion-corrected input function using the first blood
sample, which gave the best results in terms of accuracy of the AUC.
When later blood samples were used, the AUC of the IDIF was
underestimated by about 15%, essentially due to the decrease of
the signal-to-noise ratio in the measurement of late blood samples.
It was hence preferable to scale the input function in the first part of
the blood time–activity curve, for which the blood activity is higher
than the noise of the blood sample measurement.
The presented IDIF approach does not require a specific
assumption concerning the shape of the initial bolus. In this study,
the 18F-FDG was injected manually and followed by a chase.
Depending on the specific activity of the 18F-FDG solution at
the time point of the injection, the volume of the bolus of 18F-
FDG could slightly vary, and the effect of the chase on the input
function was more or less pronounced. The only fundamental
condition for the 18F-FDG infusion is to perform a sufficiently fast
injection bolus to enable the visualization of the vena cava on the
PET image by observation of the bolus at first passage. If avail-
able, a combined CT/x-ray image could be used for the position-
ing of the VOI in the vena cava.
Although the shape of the bolus in the first 2 min of the IDIF
was substantially different from the reference AIF measured with
the external blood counter because of dispersion effects, the mea-
surement of CMRGlc and CMRGlc_Patlak showed remarkable ro-
bustness toward these dispersion distortions. The values obtained
for CMRGlc and CMRGlc_Patlak using the raw IDIF (Table 2, method
4) were on the same order of accuracy and precision as the values
obtained with dispersion correction (methods 1 and 2). An im-
provement in the variability of CMRGlc and CMRGlc_Patlak across
animals was, however, noticed when scaling the dispersion-
corrected IDIF with the first blood sample (method 3). In addition,
neglecting a possible underestimation of the IDIF due to spill-out
and spatial resolution limitations by fixing the correction factor
a to 1 (method 2) also showed marginal differences on the esti-
mated CMRGlc and CMRGlc_Patlak values. Therefore, the presented
IDIF extraction method seems to be particularly robust in the
estimation of glucose uptake. To minimize the invasiveness of
the 18F-FDG PET experiment undertaken on rodents by avoiding
any blood sampling, the simple use of the raw IDIF without ad-
ditional scaling (method 4) is an advisable approach, leading to
appropriate CMRGlc and CMRGlc_Patlak estimation. Moreover, this
approach does not require the additional assessment of the disper-
sion coefficients and simplifies in that way the experimental pro-
tocol. In this case, the calculation of the MRGlc by the Patlak
modeling approach seems advisable, because of its lower sensi-
tivity to the shape of the input function.
The method presented in this study to determine an IDIF was
evaluated for the particular case of 18F-FDG. However, the pro-
posed approach is expected to be applicable to other tracers, with
or without bolus dispersion correction, after a possible reevalua-
tion of the dispersion coefficients for the new tracer, provided the
positron range of the other PET radioisotopes (34) will not in-
troduce substantial loss from the vena cava VOI through spill-out
and the tracer is not strongly distributed in organs around the vena
cava, leading to spill-in contaminations. The uptake of the injected
tracer by the heart might affect the apparent dispersion between
the vena cava and the arterial tree. For the same reason, the dis-
persion parameters might need to be reevaluated for an 18F-
FDG study planned on a group of rats with major cardiovascular
modifications—due to age, disease, or specific treatments—and on
different species. Nevertheless, the reevaluation of new dispersion
coefficients should be achievable on a small-animal group of about
3–5 subjects, as supported by the present study.
CONCLUSION
The time–activity curve extracted from the vena cava in 18F-
FDG PET studies in rats can be used as an easy accessible input
function for kinetic modeling of the MRGlc, even without correc-
tion for bolus dispersion between the vena cava and the arterial
tree. The presented approach enables technically simplified and
robust MRGlc measurements in rodents, provided that the vena
cava can be placed in the axial field of view of the PET scanner
during the dynamic acquisition. Although further validations
should be undertaken in mice with reference AIF based on blood
sampling, the presented method enabled the measurement of
CMRGlc values comparable to previously published results in
mice. The presented dispersion-correction method leads to a reli-
able estimation of the 18F-FDG input function over the entire PET
acquisition time, with minimal invasiveness.
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